Briefing: ‘End of an era’ as ECB’s emergency pandemic stimulus unwinds
Strategic angle: Nearly €3tn of excess liquidity will have drained from financial system by 2027, according to ECB estimates
Editorial Staff Apr 2
Briefing: Gold is again falling sharply, with the stock market. Why it’s not behaving the way it used to during a crisis.
Strategic angle: MarketWatch explores the unusual behavior of gold prices amid stock market fluctuations.
Editorial Staff Apr 2
Briefing: European stocks plunge as tech sector faces worst day since February 3
Strategic angle: Stocks listed in Europe fell on Thursday, as investors reacted to U.S. President Donald Trump's address on the Iran war.
Editorial Staff Apr 2
Briefing: Is It Too Late To Reassess USA Rare Earth (USAR) After Recent Share Price Pullback?
Strategic angle: An analysis of USA Rare Earth's recent share price decline and its implications for investors.
Editorial Staff Apr 2
Briefing: Trump Administration Prepares 100% Tariffs on Some Imported Drugs
Strategic angle: The White House is readying a 100% tax on some imported medicines, a draft order shows.
Editorial Staff Apr 2
Briefing: Inside India newsletter: The worst might not be over for Indian equities
Strategic angle: Indian equities plunged as the Iran war triggered a record wave of foreign investor sell‑offs. Experts warn the downturn may not be over yet.
Editorial Staff Apr 2
Briefing: Stock futures sink as Trump says U.S. on track to complete Iran objectives ‘very shortly’
Strategic angle: MarketWatch reports on the decline in stock futures amid geopolitical tensions.
Editorial Staff Apr 2
Briefing: The Mercedes GLC Was Germany’s Job. Trump’s Tariffs Changed That
Strategic angle: GLC production heads to Alabama to join GLE and GLS as tariffs reshape luxury car strategy
Editorial Staff Apr 1
Briefing: Debunking claims Israeli Jews are 'stealing land' in Morocco
Strategic angle: A viral video claims Israeli Jews are reclaiming land in Morocco, but the evidence is misleading.
Editorial Staff Apr 1
Briefing: Stock market is in for 'choppy, bumpy ride' in 2026, strategist says. Why it pays to stay invested
Strategic angle: The market's worst days are often followed by the best days, according to JPMorgan Asset Management data. Investors who stay the course stand to gain the most.
Editorial Staff Apr 1
Briefing: Wall Street loses patience with Nike as turnaround drags, China weakness deepens
Strategic angle: Nike warned that its turnaround is taking longer than it expected, leading three Wall Street banks to downgrade the stock as investors lose patience.
Editorial Staff Apr 1
Briefing: No bond for amputee cornhole pro in murder case
Strategic angle: Dayton Webber, the quadruple amputee cornhole player who is facing murder charges, will continue to be held without bond as his case moves forward, a Maryland judge ruled.
Editorial Staff Apr 1
Briefing: Where Will Nu Holdings Stock Be in 10 Years?
Strategic angle: Analyzing the future potential of Nu Holdings stock over the next decade.
Editorial Staff Apr 1
Briefing: How gossiping mushroom networks share your public urination secrets
Strategic angle: Mushrooms communicate through underground networks, sharing secrets and information with their neighbors.
Editorial Staff Apr 1
Briefing: Pinterest (PINS) Fell Following Softer Outlook
Strategic angle: Pinterest's stock experiences a decline due to a weaker than expected outlook.
Editorial Staff Apr 1
Briefing: Stock Market Today: Dow Rises As Trump Gives Timetable For Truce; Nike Plunges On Earnings (Live Coverage)
Strategic angle: The Dow sees gains amid political developments while Nike's earnings report causes a significant drop.
Editorial Staff Apr 1
Stocks Recover Sharply Amid Hope for Iran War’s End
Market rebounds as investors anticipate resolution in the ongoing conflict.
Editorial Staff Apr 1
Briefing: S&P 500 Index Investors Burned In Nightmare-Scenario Market
Strategic angle: Investors in the S&P 500 Index face significant losses as market conditions worsen.
Editorial Staff Apr 1
Briefing: Morning Brief: Stocks roar back, plus our giant, action-packed Q1 roundup
Strategic angle: Stocks rebound significantly as we review the key events of Q1.
Editorial Staff Apr 1
Briefing: STAT+: The biotech scorecard for the second quarter: 23 stock-moving events to watch
Strategic angle: Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the second quarter.
Editorial Staff Apr 1